Effect of Mycobacterium tuberculosis infection on adipocyte physiology
- PMID: 29109018
- PMCID: PMC5809261
- DOI: 10.1016/j.micinf.2017.10.008
Effect of Mycobacterium tuberculosis infection on adipocyte physiology
Abstract
Tuberculosis (TB) remains as a major threat to human health worldwide despite of the availability of standardized antibiotic therapy. One of the characteristic of pathogenic Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis is its ability to persist in the host in a dormant state and develop latent infection without clinical signs of active disease. However, the mechanisms involved in bacterial persistence and the establishment of latency is not well understood. Adipose tissue is emerging as an important niche that favors actively replicating as well as dormant Mtb during acute and latent infection. This also suggests that Mtb can disseminate from the lungs to adipose tissue during aerosol infection and/or from adipose tissue to lungs during reactivation of latent infection. In this study, we report the interplay between key adipokine levels and the dynamics of Mtb pathogenesis in the lungs and adipose tissue using a rabbit model of pulmonary infection with two clinical isolates that produce divergent outcome in disease progression. Results show that markers of adipocyte physiology and function were significantly altered during Mtb infection and distinct patterns of adipokine expression were noted between adipose tissue and the lungs. Moreover, these markers were differentially expressed between active disease and latent infection. Thus, this study highlights the importance of targeting adipocyte function as potential target for developing better TB intervention strategies.
Keywords: Adiponectin; Adipose tissue; Inflammation; Latency; Tuberculosis.
Copyright © 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
None of the authors have conflict of interest.
Figures
References
-
- Global tuberculosis report. http://www.who.int/tb/publications/global_report/gtbr15_main_text.pdf.
-
- Oni T, Stoever K, Wilkinson RJ. Tuberculosis, HIV, and type 2 diabetes mellitus: a neglected priority. Lancet Respir Med. 2013;1:356–58. - PubMed
-
- Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–49. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
